Cancer Health Services & Implementation Science Researchers @PeterMacCC. Dedicated to optimising healthcare service delivery and improving patient experience.
This is a positive step towards equity. However, like all recommendations it comes down the the effectiveness of implementation and the fact that the true cost of research is never covered by our funding models. Will be interesting to see how big pharma adopt these. @PeterMacRes
For the first time, WHO offers recommendations for national health authorities, regulators, and funders to improve clinical trials.
The guidance addresses issues like poor trial design, lack of diversity and inclusion of at-risk populations, infrastructure gaps, and inefficiencies that delay progress.
https://t.co/hyMo975Wsh
Big news in #melanoma research!
A/Prof @SandhuShahneen has received a $5M @nhmrc Synergy Grant to lead groundbreaking work that could revolutionise our understanding of melanoma treatment.
Read more: https://t.co/IXdEBOeaue
Our Supportive Care 2030 Movement Ambition Statements are now published in the @TheLancet's @eClinicalMed.
@CancerCareMASCC as the pre-eminent leader in #supponc will work with our partners around the globe to achieve these share ambitions.
Full Article https://t.co/rMaAFRm86r
Our Supportive Care 2030 Movement Ambition Statements are now published in the @TheLancet's @eClinicalMed.
@CancerCareMASCC as the pre-eminent leader in #supponc will work with our partners around the globe to achieve these share ambitions.
Full Article https://t.co/rMaAFRm86r
Today, September 13th marks World Sepsis Day where we shine a light on early recognition to save lives of our patients with cancer- Know the risks, spot the signs, Think Sepsis Act Fast. @NCICancer@sepsisAU@CNSA_ORG@PeterMacCC
@CraigUnderhill@bordermail We are very fortunate to have the opportunity for you to work with us on many important research initiatives. Your voice and advocacy for equity in cancer is incredibly important.
Watch this patient case study video, from the MS Medical Grand Rounds meeting in Melbourne, Australia, in which Professor Anneke van der Walt considers how patient-reported outcomes (PROs) can be used in clinical practice.
“MASCC definitely changed my career”. Listen as Dr Henry Wong shares the impact MASCC has had on his career working at a public community hospital in Hong Kong.
Learn more about becoming a member here: https://t.co/JO4OgoH6k1
#SuppOnc@CorinavdHurk@JuliaLaiKwon
Great study. This approach should underpin any implementation - you need to know barriers and facilitators from a funding, guideline, institutional, and clinician level. Systems thinking is one methodology. Of course local factors including culture will differ between orgs.
Half of all non relapse mortality deaths in CAR-T are due to infection - optimising a collaborative model of care, sepsis pathways and prophylaxis strategies are all important.
Just out @NatureMedicine meta-analysis >7600 CAR T pts led by @DavidCdSMD & @KRejeski
- Non-relapse mortality post CAR-T = 6.8%
- highest w ciltacel (15%) & brexucel (10.6%)
- axicel (7%) > tisa-/lisocel (4%) for LBCL
- 51% of NRM deaths from infection
https://t.co/Bw5lo1PZvZ
Improvement toolkits & good practice databases are useful but they only take us so far. As much as 80% of the knowledge in an organisation isn't written down. It's not a failure of documentation. it's to do with the nature of the knowledge and the way it gets spread. That's why it is critical that we make time & space for networks, communities of learning/practice, huddles & sharing conversations if we want change & improvement to happen: https://t.co/10ikbAwVBe. Thanks @nickknoco
Dr. Seth Gammon says he hopes PET scans and SUV numbers can be used to further personalize cancer care.
“We’re always researching ways to make this technology work toward better treatments and prevention.” https://t.co/oa0rBhmuwy @flyntlesley#EndCancer
Are you keen to learn more about stakeholder involvement in #impsci projects? Register for the #ESPACOMP 2024 Implementation Science Workshop on November 23 in Naples! https://t.co/Jn5krG1pHS
Program: https://t.co/yqXiGFLQK6
@SocMedAdherence @implementEIC
Comparative effectiveness of implementation strategies for Accelerating Cervical Ca Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria | Implementation Science https://t.co/1rZNytlmOH
Opening plenary at #MASCC24 is addressing immunotherapy toxicities. A key takeaway is that there is no consensus definition of a cancer survivor treated with immunotherapies. #irAEs
Great to see so many Peter Mac nurses at the @CNSA_ORG annual congress in Brisbane this week. Thank you for sharing Peter Mac's nurse-led research and innovation with cancer nurses from all over Australia!